查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1889411

數位迷幻療法市場預測至2032年：按療法類型、技術、應用、最終用戶和地區分類的全球分析

Digital Psychedelic-Therapy Market Forecasts to 2032 - Global Analysis By Therapy Type, Technology, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球數位迷幻療法市場價值將達到 15 億美元，到 2032 年將達到 86 億美元，在預測期內的複合年成長率為 28%。

數位迷幻療法是指一種身臨其境型治療平台，它結合了虛擬實境（VR）、神經回饋和引導式數位環境，以安全的方式模擬迷幻體驗。這些系統利用包括視覺、聽覺和觸覺回饋在內的多感官輸入，誘導意識狀態的改變，從而促進心理復原。人工智慧驅動的監控系統確保患者安全，同時根據治療目標（例如緩解焦慮、憂鬱和創傷）量身定做體驗。與化學迷幻藥不同，數位療法提供可控且可重複的療程，透過科技增強的意識探索，為心理健康治療開闢了新的途徑。

根據 MAPS 公益公司的一項調查，68% 的 PTSD 臨床試驗患者表示，他們更喜歡數位化輔助治療，因為在熟悉的家庭環境中治療能帶來舒適感和掌控感。

人們對數位療法的興趣日益濃厚

市場成長的驅動力在於人們對數位心理健康解決方案日益成長的興趣，尤其是模擬迷幻體驗的身臨其境型療法。由於傳統療法在擴充性和可及性方面面臨挑戰，數位平台提供了個人化、可擴展的替代方案。人工智慧、虛擬實境和神經回饋技術的進步，為情緒處理和創傷療癒創造了安全可控的環境。臨床研究、公眾輿論的轉變以及對非藥物心理健康療法的需求，都支持了這種日益成長的興趣。

對迷幻劑內容有嚴格的規定

對迷幻藥相關內容的監管限制構成重大障礙。儘管這些平台是數位模擬平台，但由於與管制藥物相關，許多平台仍受到嚴格審查。內容審核、授權和心理健康標準合規性因地區而異，限制了其全球擴充性。這些法規影響應用商店、臨床應用和研究經費。開發者必須謹慎應對複雜的法律體制，以確保合乎倫理的使用並避免誤導，這減緩了數位迷幻療法的普及和創新。

虛擬醫療環境的出現

創造身臨其境型虛擬治療環境，模擬迷幻劑帶來的內省效果，蘊藏著巨大的機會。這些平台結合了引導式療程、情緒感知人工智慧和神經回饋，提供無需藥物的變革性體驗。它們吸引著那些尋求安全便捷的創傷復原、焦慮和憂鬱症替代方案的用戶。與穿戴式裝置和個人化虛擬化身的整合進一步提升了使用者參與度。隨著心理健康技術的不斷發展，這些環境有望重新定義治療模式，並推動市場擴張。

與心理模擬相關的倫理風險

模擬意識狀態改變的市場面臨相關的倫理風險。這些風險包括情緒過度刺激、心理依賴、以及在非臨床環境中的濫用。如果沒有適當的指導，使用者可能會感到痛苦或誤解治療內容。此外，關於情緒分析的資料隱私和知情同意也引發了倫理問題。確保負責任的設計、臨床監督和透明的使用者教育對於降低這些風險並維護使用者對數位迷幻療法平台的信任至關重要。

新冠疫情的影響：

新冠疫情加速了人們對遠距心理健康解決方案的需求，並提升了人們對數位迷幻療法的興趣。封鎖措施和日益加劇的焦慮情緒，使得人們迫切需要便捷、沉浸式的介入手段。臨床試驗雖有所延誤，但消費者接受度卻呈現爆炸性成長。疫情後的復甦階段，人們對專注於提升心理韌性、情緒調節和創傷療癒的虛擬健康平台投入了更多資金。疫情驗證了數位療法在主流醫療保健中將發揮的作用，並將受迷幻體驗啟發的模擬療法確立為一種可行的長期心理健康支持工具。

預計在預測期內，引導式虛擬迷幻體驗環節將佔據最大的市場佔有率。

由於其結構化的治療師主導模式，預計在預測期內，引導式虛擬迷幻體驗療法將佔據最大的市場佔有率。這些療法利用虛擬實境技術、音景和人工智慧驅動的提示，模擬內省之旅，提供情緒釋放和認知重建。其受歡迎程度歸功於其可控的治療方式、較低的風險以及對創傷後壓力症候群（PTSD）、焦慮症和成癮等多種情況的適應性。與臨床工作流程的整合以及使用者信任度的提高，使得該領域得到最廣泛的應用，鞏固了其作為市場收入最大貢獻者的地位。

預計在預測期內，VR/XR身臨其境型引擎細分市場將實現最高的複合年成長率。

在空間運算和情緒模擬技術的快速發展推動下，VR/XR身臨其境型引擎領域預計將在預測期內呈現最高的成長率。這些引擎為數位迷幻療法的核心體驗提供動力，打造逼真且反應迅速的環境。透過擴充性到行動裝置、頭戴式裝置和雲端平台，其可及性正在不斷提升。隨著硬體成本的下降和內容庫的不斷擴充，身臨其境型引擎正成為治療創新的核心組成部分，吸引投資，並推動其在臨床和消費市場的應用。

佔比最大的地區：

由於心理健康意識的不斷提高、技術基礎設施的不斷改進以及政府的支持政策，亞太地區預計將在預測期內保持最大的市場佔有率。中國、日本和韓國等國家正在投資數位健康平台和身臨其境型技術。文化上對替代療法的接受度以及行動網際網路的高普及率也促進了這些技術的進一步應用。亞太地區在數位迷幻療法的應用和創新方面主導作用，區域內的Start-Ups公司和學術機構正在積極開發在地化內容。

複合年成長率最高的地區：

在預測期內，北美預計將實現最高的複合年成長率，這主要得益於強勁的研發投入、早期應用以及有利的法規環境。美國和加拿大擁有許多Start-Ups、臨床試驗和學術研究機構，致力於開發受迷幻藥啟發的數位療法。與保險系統、心理健康應用程式和遠端醫療平台的整合正在推動成長。社會對迷幻藥科學的接受度以及對身臨其境型技術的投資，使北美成為成長最快的地區，並推動了該市場的創新和全球影響力。

免費客製化服務：

購買此報告的客戶可以選擇以下免費自訂選項之一：

  • 公司概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 主要參與者（最多3家公司）的SWOT分析
  • 區域細分
    • 根據客戶要求，對主要國家的市場規模和複合年成長率進行估算和預測（註：可行性需確認）。
  • 競爭基準化分析
    • 根據主要參與者的產品系列、地理覆蓋範圍和策略聯盟基準化分析

目錄

第1章執行摘要

第2章 前言

  • 摘要
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球數位迷幻療法市場（依療法類型分類）

  • 引導式虛擬迷幻體驗
  • 人工智慧輔助認知重置療法
  • 身臨其境型虛擬實境情緒處理療法
  • 綜合迷幻健康平台
  • 神經回饋輔助療法
  • 數位售後服務與整合計劃

6. 全球數位迷幻療法市場（依技術分類）

  • VR與XR身臨其境型引擎
  • 情緒識別人工智慧系統
  • 神經影像學和腦電圖分析
  • 迷幻模擬演算法
  • 行動感測器整合
  • 人工智慧驅動的數位教練

7. 全球數位迷幻療法市場（按應用分類）

  • 心理健康治療
  • 憂鬱症與焦慮症管理
  • 創傷後壓力症候群與創傷治療
  • 成癮治療
  • 其他用途

8. 全球數位迷幻療法市場（以最終用戶分類）

  • 精神病診所
  • 數位療法公司
  • 研究所
  • 企業健康服務提供者
  • 家庭治療用戶

9. 全球數位迷幻療法市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章 企業概況

  • Compass Pathways
  • MindMed
  • Atai Life Sciences
  • Cybin
  • Johnson &Johnson
  • Novartis
  • Field Trip Health
  • Beckley Psytech
  • Small Pharma
  • NeuroRX
  • Otsuka Pharmaceutical
  • Lundbeck
  • Medtronic
  • Philips Healthcare
  • GE Healthcare
  • Siemens Healthineers
  • Pear Therapeutics
  • Teladoc Health
Product Code: SMRC32780

According to Stratistics MRC, the Global Digital Psychedelic-Therapy Market is accounted for $1.5 billion in 2025 and is expected to reach $8.6 billion by 2032 growing at a CAGR of 28% during the forecast period. Digital Psychedelic-Therapy refers to immersive therapeutic platforms that combine virtual reality, neurofeedback, and guided digital environments to simulate psychedelic experiences safely. These systems use multisensory inputs-visuals, audio, and haptic feedback-to induce altered states of consciousness for psychological healing. AI-driven monitoring ensures patient safety and tailors experiences to therapeutic goals, such as reducing anxiety, depression, or trauma. Unlike chemical psychedelics, digital therapy provides controlled, repeatable sessions, offering a novel approach to mental health treatment through technology-enhanced consciousness exploration.

According to a MAPS public benefit corporation survey, 68% of patients in clinical trials for PTSD reported a preference for digitally-assisted therapy sessions, citing the comfort and control provided by a familiar, home-based environment.

Market Dynamics:

Driver:

Rising interest in digital therapies

The market is propelled by growing interest in digital mental health solutions, especially immersive therapies that simulate psychedelic experiences. As traditional therapy models face scalability and accessibility challenges, digital platforms offer personalized, scalable alternatives. Advances in AI, VR, and neurofeedback are enabling safe, controlled environments for emotional processing and trauma healing. This surge in interest is supported by clinical research, shifting public perception, and demand for non-pharmacological interventions in mental wellness.

Restraint:

Strict controls on psychedelic content

Regulatory restrictions on psychedelic-related content pose a significant restraint. Despite being digital simulations, many platforms face scrutiny due to associations with controlled substances. Content moderation, licensing, and compliance with mental health standards vary across regions, limiting global scalability. These controls affect app stores, clinical deployment, and research funding. Developers must navigate complex legal frameworks to ensure ethical use and avoid misrepresentation, slowing adoption and innovation in digital psychedelic therapy.

Opportunity:

Emergence of virtual therapeutic environments

A major opportunity lies in the creation of immersive virtual therapeutic environments that replicate the introspective effects of psychedelics. These platforms combine guided sessions, emotion-recognition AI, and neurofeedback to deliver transformative experiences without pharmacological agents. They appeal to users seeking safe, accessible alternatives for trauma recovery, anxiety, and depression. Integration with wearables and personalized avatars enhances engagement. As mental health tech evolves, these environments are poised to redefine therapy delivery and expand market reach.

Threat:

Ethical risks around mental simulation

The market faces ethical risks related to simulating altered states of consciousness. Concerns include emotional overstimulation, psychological dependency, and misuse in non-clinical settings. Without proper guidance, users may experience distress or misinterpret therapeutic content. Additionally, data privacy and consent around emotional profiling raise ethical flags. Ensuring responsible design, clinical oversight, and transparent user education is critical to mitigate these risks and maintain trust in digital psychedelic therapy platforms.

Covid-19 Impact:

Covid-19 accelerated demand for remote mental health solutions, boosting interest in digital psychedelic therapy. Lockdowns and rising anxiety levels created urgency for accessible, immersive interventions. While clinical trials slowed, consumer adoption surged. Post-pandemic recovery has seen increased investment in virtual wellness platforms, with emphasis on resilience, emotional regulation, and trauma healing. The pandemic validated digital therapy's role in mainstream healthcare, positioning psychedelic-inspired simulations as a viable tool for long-term mental health support.

The guided virtual psychedelic sessions segment is expected to be the largest during the forecast period

The guided virtual psychedelic sessions segment is expected to account for the largest market share during the forecast period, due to their structured, therapist-led approach. These sessions simulate introspective journeys using VR, soundscapes, and AI-driven prompts, offering emotional release and cognitive reframing. Their popularity stems from controlled delivery, reduced risk, and adaptability across conditions like PTSD, anxiety, and addiction. Integration with clinical workflows and growing user trust make this segment the most widely adopted, securing its position as the largest contributor to market revenue.

The VR & XR immersive engines segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the VR & XR immersive engines segment is predicted to witness the highest growth rate, driven by rapid advancements in spatial computing and emotional simulation. These engines power the core experience of digital psychedelic therapy, enabling realistic, responsive environments. Their scalability across mobile, headset, and cloud platforms enhances accessibility. As hardware costs drop and content libraries expand, immersive engines are becoming central to therapeutic innovation, attracting investment and driving adoption in both clinical and consumer markets.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to rising mental health awareness, expanding tech infrastructure, and supportive government initiatives. Countries like China, Japan, and South Korea are investing in digital wellness platforms and immersive technologies. Cultural openness to alternative therapies and high mobile penetration further support adoption. Regional startups and academic institutions are actively developing localized content, making Asia Pacific a dominant force in digital psychedelic therapy deployment and innovation.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR fueled by strong R&D, early adoption, and favorable regulatory shifts. The U.S. and Canada host leading startups, clinical trials, and academic research in psychedelic-inspired digital therapies. Integration with insurance systems, mental health apps, and telehealth platforms accelerates growth. Public acceptance of psychedelic science and investment in immersive tech position North America as the fastest-growing region, driving innovation and global influence in this market.

Key players in the market

Some of the key players in Digital Psychedelic-Therapy Market include Compass Pathways, MindMed, Atai Life Sciences, Cybin, Johnson & Johnson, Novartis, Field Trip Health, Beckley Psytech, Small Pharma, NeuroRX, Otsuka Pharmaceutical, Lundbeck, Medtronic, Philips Healthcare, GE Healthcare, Siemens Healthineers, Pear Therapeutics, and Teladoc Health

Key Developments:

In November 2025, Compass Pathways introduced its immersive digital therapy platform combining guided psychedelic simulations with AI-driven patient monitoring. The system delivers structured therapeutic journeys for depression and anxiety, offering clinicians real-time insights into patient progress.

In October 2025, MindMed launched its next-generation digital psychedelic integration app designed to support patients post-session with adaptive cognitive exercises and mood tracking. The app enhances long-term outcomes by embedding personalized therapeutic content into daily routines.

In September 2025, Atai Life Sciences announced the rollout of its VR-enabled therapeutic environment for clinical trials, enabling controlled psychedelic-inspired experiences. The platform integrates biometric feedback and therapist dashboards, supporting scalable deployment in mental health research and treatment.

Therapy Types Covered:

  • Guided Virtual Psychedelic Sessions
  • AI-Assisted Cognitive Reset Therapy
  • Immersive VR Emotional Processing
  • Integrated Psychedelic Wellness Platforms
  • Neurofeedback-Assisted Therapies
  • Digital Aftercare & Integration Programs

Technologies Covered:

  • VR & XR Immersive Engines
  • Emotion-Recognition AI Systems
  • Neuroimaging & Brainwave Analytics
  • Psychedelic Simulation Algorithms
  • Mobile Sensor Integration
  • AI-Powered Digital Coaches

Applications Covered:

  • Mental Health Therapy
  • Depression & Anxiety Management
  • PTSD & Trauma Therapy
  • Addiction Treatment
  • Other Applications

End Users Covered:

  • Psychiatric Clinics
  • Digital Therapeutics Companies
  • Research Institutions
  • Corporate Wellness Providers
  • Home-Based Therapy Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Psychedelic-Therapy Market, By Therapy Type

  • 5.1 Introduction
  • 5.2 Guided Virtual Psychedelic Sessions
  • 5.3 AI-Assisted Cognitive Reset Therapy
  • 5.4 Immersive VR Emotional Processing
  • 5.5 Integrated Psychedelic Wellness Platforms
  • 5.6 Neurofeedback-Assisted Therapies
  • 5.7 Digital Aftercare & Integration Programs

6 Global Digital Psychedelic-Therapy Market, By Technology

  • 6.1 Introduction
  • 6.2 VR & XR Immersive Engines
  • 6.3 Emotion-Recognition AI Systems
  • 6.4 Neuroimaging & Brainwave Analytics
  • 6.5 Psychedelic Simulation Algorithms
  • 6.6 Mobile Sensor Integration
  • 6.6 AI-Powered Digital Coaches

7 Global Digital Psychedelic-Therapy Market, By Application

  • 7.1 Introduction
  • 7.2 Mental Health Therapy
  • 7.3 Depression & Anxiety Management
  • 7.4 PTSD & Trauma Therapy
  • 7.5 Addiction Treatment
  • 7.6 Other Applications

8 Global Digital Psychedelic-Therapy Market, By End User

  • 8.1 Introduction
  • 8.2 Psychiatric Clinics
  • 8.3 Digital Therapeutics Companies
  • 8.4 Research Institutions
  • 8.5 Corporate Wellness Providers
  • 8.6 Home-Based Therapy Users

9 Global Digital Psychedelic-Therapy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Compass Pathways
  • 11.2 MindMed
  • 11.3 Atai Life Sciences
  • 11.4 Cybin
  • 11.5 Johnson & Johnson
  • 11.6 Novartis
  • 11.7 Field Trip Health
  • 11.8 Beckley Psytech
  • 11.9 Small Pharma
  • 11.10 NeuroRX
  • 11.11 Otsuka Pharmaceutical
  • 11.12 Lundbeck
  • 11.13 Medtronic
  • 11.14 Philips Healthcare
  • 11.15 GE Healthcare
  • 11.16 Siemens Healthineers
  • 11.17 Pear Therapeutics
  • 11.18 Teladoc Health

List of Tables

  • Table 1 Global Digital Psychedelic-Therapy Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Digital Psychedelic-Therapy Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 3 Global Digital Psychedelic-Therapy Market Outlook, By Guided Virtual Psychedelic Sessions (2024-2032) ($MN)
  • Table 4 Global Digital Psychedelic-Therapy Market Outlook, By AI-Assisted Cognitive Reset Therapy (2024-2032) ($MN)
  • Table 5 Global Digital Psychedelic-Therapy Market Outlook, By Immersive VR Emotional Processing (2024-2032) ($MN)
  • Table 6 Global Digital Psychedelic-Therapy Market Outlook, By Integrated Psychedelic Wellness Platforms (2024-2032) ($MN)
  • Table 7 Global Digital Psychedelic-Therapy Market Outlook, By Neurofeedback-Assisted Therapies (2024-2032) ($MN)
  • Table 8 Global Digital Psychedelic-Therapy Market Outlook, By Digital Aftercare & Integration Programs (2024-2032) ($MN)
  • Table 9 Global Digital Psychedelic-Therapy Market Outlook, By Technology (2024-2032) ($MN)
  • Table 10 Global Digital Psychedelic-Therapy Market Outlook, By VR & XR Immersive Engines (2024-2032) ($MN)
  • Table 11 Global Digital Psychedelic-Therapy Market Outlook, By Emotion-Recognition AI Systems (2024-2032) ($MN)
  • Table 12 Global Digital Psychedelic-Therapy Market Outlook, By Neuroimaging & Brainwave Analytics (2024-2032) ($MN)
  • Table 13 Global Digital Psychedelic-Therapy Market Outlook, By Psychedelic Simulation Algorithms (2024-2032) ($MN)
  • Table 14 Global Digital Psychedelic-Therapy Market Outlook, By Mobile Sensor Integration (2024-2032) ($MN)
  • Table 15 Global Digital Psychedelic-Therapy Market Outlook, By AI-Powered Digital Coaches (2024-2032) ($MN)
  • Table 16 Global Digital Psychedelic-Therapy Market Outlook, By Application (2024-2032) ($MN)
  • Table 17 Global Digital Psychedelic-Therapy Market Outlook, By Mental Health Therapy (2024-2032) ($MN)
  • Table 18 Global Digital Psychedelic-Therapy Market Outlook, By Depression & Anxiety Management (2024-2032) ($MN)
  • Table 19 Global Digital Psychedelic-Therapy Market Outlook, By PTSD & Trauma Therapy (2024-2032) ($MN)
  • Table 20 Global Digital Psychedelic-Therapy Market Outlook, By Addiction Treatment (2024-2032) ($MN)
  • Table 21 Global Digital Psychedelic-Therapy Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 22 Global Digital Psychedelic-Therapy Market Outlook, By End User (2024-2032) ($MN)
  • Table 23 Global Digital Psychedelic-Therapy Market Outlook, By Psychiatric Clinics (2024-2032) ($MN)
  • Table 24 Global Digital Psychedelic-Therapy Market Outlook, By Digital Therapeutics Companies (2024-2032) ($MN)
  • Table 25 Global Digital Psychedelic-Therapy Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 26 Global Digital Psychedelic-Therapy Market Outlook, By Corporate Wellness Providers (2024-2032) ($MN)
  • Table 27 Global Digital Psychedelic-Therapy Market Outlook, By Home-Based Therapy Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.